1. Stock Market
  2. Stock Market News in real time
  3. Actinogen Doses First Patient in Phase 2b Alzheimer’s Disease Trial; Shares Rally 16%
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW